Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of ciclesonide.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Ciclesonide

Criteria

Main inclusion criteria:

• History of persistent bronchial asthma

Main exclusion criteria:

• Hypersensitive to compounds of Alvesco

• Other criteria as defined in the Summary of Product Characteristics (Fachinformation Chapter 4.3)